Business, energy, technology, markets and global industry news from Business News Today

drug-resistant epilepsy

Pharma & Biotech

Can Neurona Therapeutics validate regenerative cell therapy in epilepsy with Phase 3 EPIC trial

Neurona Therapeutics’ rezanecel shows durable seizure reduction in epilepsy. Discover what this means for cell therapy innovation and future treatment pathways.

Read More